Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001237832 | SCV001410612 | pathogenic | not provided | 2024-02-02 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 458 of the TCIRG1 protein (p.Gly458Ser). This variant is present in population databases (rs200851583, gnomAD 0.003%). This missense change has been observed in individual(s) with osteopetrosis (PMID: 28604959, 30539151, 30898715). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 553699). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TCIRG1 protein function with a positive predictive value of 80%. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. |
Molecular Lab, |
RCV000669207 | SCV002516045 | pathogenic | Autosomal recessive osteopetrosis 1 | 2022-05-20 | criteria provided, single submitter | clinical testing | |
3billion, |
RCV000669207 | SCV002572945 | likely pathogenic | Autosomal recessive osteopetrosis 1 | 2022-09-01 | criteria provided, single submitter | clinical testing | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.98; 3Cnet: 0.97). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with TCIRG1-related disorder (ClinVar ID: VCV000553699 / PMID: 22231430). The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least 2 similarly affected unrelated individuals (PMID: 30539151). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. |
Baylor Genetics | RCV000669207 | SCV004205769 | pathogenic | Autosomal recessive osteopetrosis 1 | 2024-02-20 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000669207 | SCV000793937 | uncertain significance | Autosomal recessive osteopetrosis 1 | 2017-09-07 | flagged submission | clinical testing | |
Natera, |
RCV000669207 | SCV002094913 | likely pathogenic | Autosomal recessive osteopetrosis 1 | 2020-09-21 | no assertion criteria provided | clinical testing |